PFE FY2025 SEC EDGAR DEF 14A #7 of 168 in industry

Pfizer Inc CEO pay ratio

The CEO earned $27.6M in FY2025 against median worker pay of $99,586 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-03-12
Industry
Chemicals & Pharmaceuticals
Industry rank
#7/168

Data updated August 2026

Subscribe to Pfizer Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
277:1
High (Scale: 0–1000:1)
CEO pay
$27.6M
Median worker
$99,586

Answer first

Pfizer Inc's FY2025 CEO total of $27.6M ranks #81 of 1,423 complete filings; its 277:1 pay ratio ranks #218. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $99,586. Industry placement uses the FY2025 SIC-28 peer cohort (# 7 of 168, 96th percentile - top 5% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#81
$27.6M of 1,423 FY2025
Ratio rank
#218
277:1 of 1,423
Industry pct
96th
top 5% of industry peers by pay ratio

How Pfizer Inc ranks nationally

Pfizer Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$27,585,301 Top 6% higher than 94% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). Below this entry. $22,500,000–$25,000,000: 34 companies (2%). Below this entry. $25,000,000–$27,500,000: 24 companies (2%). Below this entry. $27,500,000–$30,000,000: 16 companies (1%). This entry sits in this band. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Pfizer Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($27.6M) against pay ratio (277:1) for Pfizer Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6132911.514138142.022143372.530148603.038153833.529.4:198.5:1167.5:1236.5:1305.6:1CEO total payPay ratio (CEO : median worker)Pfizer Inc, CEO total pay: 27585301 · Pay ratio (CEO : median worker): 277:1Pfizer IncHarrow, Inc., CEO total pay: 23606274 · Pay ratio (CEO : median worker): 263:1Harrow, Inc.ELI LILLY & Co, CEO total pay: 36698337 · Pay ratio (CEO : median worker): 293:1ELI LILLY & CoTeva Pharmaceutical Industries Ltd, CEO total pay: 19168709 · Pay ratio (CEO : median worker): 257:1Teva Pharmaceutical Industries LtdTrulieve Cannabis Corp., CEO total pay: 7588408 · Pay ratio (CEO : median worker): 243:1Trulieve Cannabis Corp.International Flavors & Fragrances Inc, CEO total pay: 15015892 · Pay ratio (CEO : median worker): 239:1International Flavors & Fragrances Inc
Pfizer Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Pfizer Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Pfizer Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
277:1
FY2025
vs prior FY
+8:1
from FY2024 269:1
CEO $ YoY
+12%
$27.6M latest
Filings shown
4
FY2022–2025
Pfizer Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $33.0M - $75,555 437:1 -
2023 $21.6M -35% $74,096 291:1 -146:1
2024 $24.6M +14% $91,631 269:1 -22:1
2025 $27.6M +12% $99,586 277:1 +8:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 78003, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
277:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$27.6M
Companies in Industry
168
vs. Industry Median
Above
#7 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Pfizer Inc: STEEP · PEAK pay ratio

Pfizer Inc's FY2025 ratio 277:1 ranks #7 of 168 Chemicals & Pharmaceuticals filers (96th percentile). the CEO earned 277× the median employee ($99,586) in FY2025.

Median employee $99,586 (HIGH-MED); STEEP · PEAK stamps put about 277 median-wage years per CEO year.

CEO Total Pay

$27.6M

FY2025 Summary Compensation, well above median

Pay Ratio

277:1

Elevated vs. peers

Pfizer Inc in the higher Chemicals & Pharmaceuticals third

Pfizer Inc's FY2025 ratio 277:1 ranks #7 of 168 Chemicals & Pharmaceuticals filers (96th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Pfizer Inc's $27.6M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #81 and ratio rank #218 split - treat 277:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$27.6M
Median Employee Pay
$99,586
Pay Ratio
277:1
Filing Date
2026-03-12

Company Info

Ticker
PFE
CIK
78003
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 78003, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Pfizer Inc's FY2025 ratio 277:1 ranks #7 of 168 Chemicals & Pharmaceuticals filers (96th percentile).

Read with Pfizer Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.

Mueller Industries Inc · PEAK

ABS(ceo_total_comp) peer at $27.5M (Δ $42K lighter vs Pfizer Inc); EXTREME · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Ford Motor Co · PEAK

ABS(ceo_total_comp) peer at $27.5M (Δ $66K lighter vs Pfizer Inc); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
Hilton Worldwide Holdings Inc. · PEAK

ABS(ceo_total_comp) peer at $27.7M (Δ $107K heavier vs Pfizer Inc); EXTREME · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Analog Devices Inc · PEAK

ABS(ceo_total_comp) peer at $27.5M (Δ $129K lighter vs Pfizer Inc); EXTREME · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Harrow, Inc. (SIC 28 pole)

Harrow, Inc. stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Pfizer Inc's STEEP filing.
National dual ranks · #81/#218

Pfizer Inc's FY2025 package sits #81 by CEO dollars and #218 by ratio under PEAK · STEEP.
Comp structure · PEAK

Pfizer Inc's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Pfizer Inc (CIK 78003), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.